Orbi-Pharma International SRL
2.2 FTEThe score of Orbi-Pharma International shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -65 % Headcount (avg FTE) -100 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Orbi-Pharma International's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −42,359 € | ||||
| Equity | −247,268 € | ||||
| Cash | 1,021 € | ||||
| EBITDA | −16,592 € | ||||
| Total assets | 161,674 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 27 Feb 2026
- Year ended 30 Jun 2024filed on 27 Feb 2025
- Year ended 30 Jun 2023filed on 16 Feb 2024
- Year ended 30 Jun 2022filed on 27 Jan 2023
- Year ended 30 Jun 2021filed on 27 Jan 2022
Orbi-Pharma International's financial analysis
- Solvency-152.9%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Orbi-Pharma International
Orbi-Pharma International's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0899.434.280
- VAT number
- BE0899434280
- Peppol
- Registered · 0208:0899434280 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Jul 2008
- Registered office
- 3360 Bierbeek
- Size
- Micro · 2.2 FTE
- Latest accounts
- 2025 · filed on 27 Feb 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Orbi-Pharma International (SRL) has been based in Bierbeek since 2008, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 42,359 € and equity of −247,268 €; its revenue is not published. With 2.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -152.9%, below the median of its sector (46.0%).
Companies similar to Orbi-Pharma International
Companies in the same business, of comparable size and area, outside its group.
- GUANG JI Pharmaceutical Belgium sa Business and other management consultancy activities Ottignies-Louvain-la-Neuve · balance sheet 32,994 €
- Turmali Business and other management consultancy activities Bredene · balance sheet 108,587 €
- JVHealth Business and other management consultancy activities Ronse · balance sheet 76,935 €
- Vetwise Business and other management consultancy activities Sint-Niklaas · balance sheet 62,537 €
- DE Dommel Business and other management consultancy activities Waasmunster · balance sheet 730,988 €
- Verachtert Digital Manufacture of medical and dental instruments and supplies Antwerp · balance sheet €1.08m
- Extraphar Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 10,258 €
- Vervloet MSM Wholesale of pharmaceutical and medical goods Sint-Niklaas · balance sheet 189,219 €
Frequently asked questions about Orbi-Pharma International
What is the revenue of Orbi-Pharma International?
Orbi-Pharma International files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Orbi-Pharma International?
In Belgium, the VAT number is the company number prefixed with BE: BE0899434280 for Orbi-Pharma International, if the company is VAT-registered. Its company number (CBE) is 0899.434.280.
Where is the registered office of Orbi-Pharma International?
According to the CBE register, the registered office of Orbi-Pharma International is in 3360 Bierbeek.
What is the equity of Orbi-Pharma International?
At the close of the 2025 financial year, the equity of Orbi-Pharma International amounts to -247,268 €, a solvency of -152.9% of total assets.
How many people work at Orbi-Pharma International?
2.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Orbi-Pharma International?
The register lists 2 active mandates at Orbi-Pharma International. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Orbi-Pharma International
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →